IAG Capital Partners — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Cerberus is a multi-platform investment firm that manages capital across diverse asset classes including direct lending, private equity, real estate, credit, and venture capital.
Enterprise SoftwareFintechNew York, US
Co-investorsAHL Venture PartnersBooz Allen VenturesClean Energy VenturesBallistic VenturesForgePoint CapitalSafar Partners+1 more
DeepCure uses AI and machine learning to accelerate drug discovery and development for treating diseases.
AI & Machine LearningBiotechDigital HealthHealthtech
Kfir Schreiber(CEO & Co-Founder)inThrasyvoulos Karydis(CTO & Co-Founder)inJoseph Jacobson(Co-Founder)in
PartnerJoel Whitley· solo GP
Co-investorsThe E14 FundTLV Partners
Enfabrica develops networking silicon and infrastructure for AI and accelerated computing, using a multi-path switched fabric that connects CPUs, GPUs, and memory endpoints with fault tolerance and load distribution.
AI & Machine LearningData & InfrastructureSemiconductorsMountain View, US
Shrijeet Mukerjee(Director)Rochan Sankar(Executive Officer, Director)inShrijeet Mukherjee(Founder)in
BoardGavin Baker(Director)Stefan Dyckerhoff(Director)
Co-investorsAlumni VenturesBasecamp FundCastor Ventures (an Alumni Ventures Fund)Cisco InvestmentsProsperity7 VenturesSamsung Catalyst Fund+7 more
Lightsynq develops optical quantum interconnects using integrated diamond photonic circuits to enable scaling of fault-tolerant quantum computers.
Deep TechQuantum Computing
Co-investorsGrit VenturesSafar PartnersTop Corner CapitalCerberus Ventures
Fort Lee, US
Alexander Gaeta(Executive Officer, Director)inVivek Raghunathan(Executive Officer, Director)inYoshitomo Okawachi(Executive Officer)Alexander Kash(Executive Officer, Director)
BoardJames Scapa(Director)
Co-investorsCisco InvestmentsOUP (Osage University Partners)FathomFathom FundLifeX VenturesNVIDIA
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.